| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Eef Lien Theunissen, Kim Paula Colette Kuypers, Natasha Leigh Mason, Johannes Gerardus Ramaeker. A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence. Frontiers in psychiatry. vol 13. 2022-06-06. PMID:35664482. |
due to differences in potency, efficacy, and affinity for cb1 receptors, similarities and differences in psychoactive effect profiles of natural cannabis and synthetic cannabinoids (scs) cannot reliably be derived from equipotent dose comparisons. |
2022-06-06 |
2023-08-14 |
human |
| Elisabet Navarro-Tapia, Jana Codina, Víctor José Villanueva-Blasco, Óscar García-Algar, Vicente Andreu-Fernánde. Detection of the Synthetic Cannabinoids AB-CHMINACA, ADB-CHMINACA, MDMB-CHMICA, and 5F-MDMB-PINACA in Biological Matrices: A Systematic Review. Biology. vol 11. issue 5. 2022-05-28. PMID:35625524. |
new synthetic cannabinoids (scs) are emerging rapidly and continuously. |
2022-05-28 |
2023-08-13 |
human |
| Muzeyyen Akar, Merve Ercin, Tugce Boran, Selda Gezginci-Oktayoglu, Gül Özha. UR-144, Synthetic Cannabinoid Receptor Agonist, Induced Cardiomyoblast Toxicity Mechanism Comprises Cytoplasmic Ca Toxicology mechanisms and methods. 2022-05-24. PMID:35606921. |
ur-144, synthetic cannabinoid receptor agonist, induced cardiomyoblast toxicity mechanism comprises cytoplasmic ca ur-144, a cannabinoid receptor agonist, is widely used alone or in combination with other synthetic cannabinoids (scs) all over the world. |
2022-05-24 |
2023-08-13 |
Not clear |
| László Institóris, Előd Hidvégi, Katalin Kovács, Ákos Jámbor, Adrienn Dobos, Ferenc Rárosi, Gábor Süvegh, Tibor Varga, Éva M Kereszt. Drug consumption of suspected drug-influenced drivers in Hungary (2016-2018). Forensic science international. vol 336. 2022-05-15. PMID:35569293. |
classical illicit drugs were detected in 76-87%, prescription medications in 9-15%, stimulant new psychoactive substances (snps) in 3-8%, and synthetic cannabinoids (scs) in 20-22% of the positive samples. |
2022-05-15 |
2023-08-13 |
Not clear |
| K M Scarfone, N Maghsoudi, K McDonald, H Thompson, C Stefan, D R Beriault, D Werb, J M Bowle. Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada. Clinical toxicology (Philadelphia, Pa.). 2022-05-13. PMID:35546568. |
presented are first known data of three newly detected synthetic cannabinoids (scs) in toronto, ontario. |
2022-05-13 |
2023-08-13 |
Not clear |
| Pille-Riin Laanet, Merike Vaher, Piret Saar-Reisma. Micellar electrokinetic chromatography method for the analysis of synthetic and phytocannabinoids. Journal of chromatography. A. vol 1673. 2022-05-04. PMID:35508096. |
synthetic cannabinoids (scs) are the largest group of illicit compounds currently monitored in europe. |
2022-05-04 |
2023-08-13 |
Not clear |
| Giorgia Vaccaro, Anna Massariol, Amira Guirguis, Stewart B Kirton, Jacqueline L Stai. NPS detection in Prison: a Systematic Literature Review of Use, Drug Form, and Analytical Approaches. Drug testing and analysis. 2022-03-31. PMID:35355411. |
findings showed the most prevalent nps class reported in prison was synthetic cannabinoids (scs). |
2022-03-31 |
2023-08-13 |
Not clear |
| Gabriel L Streun, Andrea E Steuer, Sandra N Poetzsch, Lars C Ebert, Akos Dobay, Thomas Kraeme. Towards a New Qualitative Screening Assay for Synthetic Cannabinoids Using Metabolomics and Machine Learning. Clinical chemistry. 2022-03-24. PMID:35323873. |
synthetic cannabinoids (scs) are steadily emerging on the drug market. |
2022-03-24 |
2023-08-13 |
Not clear |
| Xiaolin Fan, Jianhe Zhang, Xiaofang Fu, Bo Zhou, Zeqiong Xu, Hongmei Huang, Sheng Han, Xiqing L. Analysis of synthetic cannabinoids in wastewater of major cities in China. The Science of the total environment. 2022-03-05. PMID:35247413. |
synthetic cannabinoids (scs) could pose serious health risks to its users. |
2022-03-05 |
2023-08-13 |
Not clear |
| b' Jeremy Carlier, Diletta Berardinelli, Eva Montanari, Ascanio Sirignano, Annagiulia Di Trana, Francesco P Busard\\xc3\\xb. 3F-\\xce\\xb1-pyrrolydinovalerophenone (3F-\\xce\\xb1-PVP) in vitro human metabolism: Multiple in silico predictions to assist in LC-HRMS/MS analysis and targeted/untargeted data mining. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. vol 1193. 2022-02-18. PMID:35180546.' |
scs represent the widest nps class, second to synthetic cannabinoids, accounting for approximately 160 different analogues with substitution at the phenyl group, the amine group, or the alkyl chain. |
2022-02-18 |
2023-08-13 |
human |
| Charles A Odonkor, Tariq Alfara, Peju Adekoya, Vwaire Orhurhu, Tomás Rodríguez, Emily Sottosanti, Alan D Kay. Dorsal Column Stimulation and Cannabinoids in the Treatment of Chronic Nociceptive and Neuropathic Pain: a Review of the Clinical and Pre-clinical Data. Current pain and headache reports. 2022-02-04. PMID:35119602. |
the main objective of this review is to appraise the literature on the role of spinal cord stimulation (scs), cannabinoid therapy, as well as scs and cannabinoid combination therapy for the management of chronic neuropathic and nociceptive pain. |
2022-02-04 |
2023-08-13 |
Not clear |
| Manuela Carla Monti, Jill Zeugin, Konrad Koch, Natasa Milenkovic, Eva Scheurer, Katja Mercer-Chalmers-Bende. Adulteration of low-THC products with synthetic cannabinoids: Results from drug checking services. Drug testing and analysis. 2022-01-08. PMID:34997693. |
since late 2019, low-thc preparations adulterated with synthetic cannabinoids (scs) have been frequently observed in switzerland. |
2022-01-08 |
2023-08-13 |
Not clear |
| Yan Shi, Mengxi Liu, Xiangjun Li, Niusheng Xu, Shuai Yuan, Zhiguo Yu, Ping Xiang, Hejian W. Simultaneous screening of 239 synthetic cannabinoids and metabolites in blood and urine samples using liquid chromatography-high resolution mass spectrometry. Journal of chromatography. A. vol 1663. 2022-01-02. PMID:34974369. |
synthetic cannabinoids (scs) are new psychoactive substances that function as endocannabinoid cb1 and cb2 receptor agonists. |
2022-01-02 |
2023-08-13 |
Not clear |
| Ziteng Wang, Ching Yee Fong, Evelyn Mei Ling Goh, Hooi Yan Moy, Eric Chun Yong Cha. Transesterification of Indazole-3-Carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarker for Diagnosing Co-Abuse of 5F-MDMB-PINACA and Alcohol. Journal of analytical toxicology. 2021-12-17. PMID:34918103. |
concurrent use of alcohol with synthetic cannabinoids (scs) has been widely recorded among drug abusers. |
2021-12-17 |
2023-08-13 |
human |
| Selman Yeniocak, Asım Kalkan, Adnan Yamanoğlu, Semi Öztürk, Özgür Söğüt, Merve Metine. The effects of synthetic cannabinoids on the cardiovascular system: A case-control study. Turkish journal of emergency medicine. vol 21. issue 4. 2021-12-03. PMID:34849432. |
limited clinical studies have investigated the effects of synthetic cannabinoids (scs) on the cardiovascular system (cvs). |
2021-12-03 |
2023-08-13 |
Not clear |
| Alex F Manini, Alex J Krotulski, Jonathan Schimmel, Lisa Allen, Yasmin L Hurd, Lynne D Richardson, Kavey Vidal, Barry K Loga. Respiratory failure in confirmed synthetic cannabinoid overdose. Clinical toxicology (Philadelphia, Pa.). 2021-12-01. PMID:34499005. |
synthetic cannabinoids (scs) are a structurally heterogenous synthetic class of drugs of abuse. |
2021-12-01 |
2023-08-13 |
Not clear |
| Pinar Efeoglu Ozseker, Nebile Daglioglu, Mete Korkut Gulmen, Ilknur Tolunay, Fehiman Efeogl. Determination of AB-FUBINACA and 5F-NPB-22 in rats exposed to "Bonsai" via inhalation and analysis of seized product. Legal medicine (Tokyo, Japan). vol 50. 2021-11-08. PMID:33713938. |
synthetic cannabinoids (scs) are the most rapidly growing class of recreational designer drugs. |
2021-11-08 |
2023-08-13 |
rat |
| Fatma Dilek Gökharman, Sonay Aydin, Salih Cihat Paltun, Erdem Fatihoğlu, Şafak Yalçin Şahiner, Pinar Nercis Koşa. DTI-MRI findings in synthetic cannabinoid users Turkish journal of medical sciences. vol 50. issue 4. 2021-10-26. PMID:32336074. |
dti-mri findings in synthetic cannabinoid users synthetic cannabinoids (scs) are full agonists of both cannabinoid receptors. |
2021-10-26 |
2023-08-13 |
Not clear |
| Nadja Walle, Frederike Nordmeier, Adrian A Doerr, Benjamin Peters, Matthias W Laschke, Michael D Menger, Peter H Schmidt, Markus R Meyer, Nadine Schaefe. Comparison of in vitro and in vivo models for the elucidation of metabolic patterns of 7-azaindole-derived synthetic cannabinoids exemplified using cumyl-5F-P7AICA. Drug testing and analysis. vol 13. issue 1. 2021-10-07. PMID:32678962. |
due to the dynamic market involving synthetic cannabinoids (scs), the determination of analytical targets is challenging in clinical and forensic toxicology. |
2021-10-07 |
2023-08-13 |
human |
| John Stogner, Logan Sarvey, C Cory Lowe, Aleksi Hupli, Bryan Lee Mille. Sexual Orientation and Synthetic Cannabinoid Use: Examining the Role of Bullying Victimization. Journal of psychoactive drugs. 2021-10-05. PMID:34608853. |
studies also indicate that sexual minorities are more likely to use alcohol and other drugs, including synthetic cannabinoids (scs). |
2021-10-05 |
2023-08-13 |
human |